Ikonisys S.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was EUR 0.935218 million compared to EUR 0.542701 million a year ago. Net loss was EUR 2.45 million compared to EUR 0.571269 million a year ago.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.42 EUR | -2.07% | -2.07% | -8.97% |
Jun. 12 | Ikonisys, Ulisse Biomed to Collaborate on New Cancer Diagnostic Technologies | MT |
Jun. 03 | Ikonisys S.A. announced that it has received ?1.150001 million in funding | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.97% | 16.6M | |
-2.58% | 8.27B | |
+8.97% | 5.81B | |
+29.76% | 5.58B | |
-15.77% | 3.85B | |
+12.42% | 2.71B | |
-61.85% | 2.56B | |
-7.55% | 2.42B | |
+23.09% | 2.13B | |
-9.25% | 1.77B |
- Stock Market
- Equities
- ALIKO Stock
- News Ikonisys S.A.
- Ikonisys S.A. Reports Earnings Results for the Full Year Ended December 31, 2022